Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 136

1.

Distinguishing primary adenocarcinoma of the urinary bladder from secondary involvement by colorectal adenocarcinoma: extended immunohistochemical profiles emphasizing novel markers.

Rao Q, Williamson SR, Lopez-Beltran A, Montironi R, Huang W, Eble JN, Grignon DJ, Koch MO, Idrees MT, Emerson RE, Zhou XJ, Zhang S, Baldridge LA, Cheng L.

Mod Pathol. 2013 May;26(5):725-32. doi: 10.1038/modpathol.2012.229. Epub 2013 Jan 25.

PMID:
23348900
[PubMed - indexed for MEDLINE]
Free Article
2.

Immunohistochemical distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma.

Wang HL, Lu DW, Yerian LM, Alsikafi N, Steinberg G, Hart J, Yang XJ.

Am J Surg Pathol. 2001 Nov;25(11):1380-7.

PMID:
11684954
[PubMed - indexed for MEDLINE]
3.
4.

Immunohistochemical analysis in a morphologic spectrum of urachal epithelial neoplasms: diagnostic implications and pitfalls.

Paner GP, McKenney JK, Barkan GA, Yao JL, Frankel WL, Sebo TJ, Shen SS, Jimenez RE.

Am J Surg Pathol. 2011 Jun;35(6):787-98. doi: 10.1097/PAS.0b013e3182189c11.

PMID:
21572312
[PubMed - indexed for MEDLINE]
5.

Is GATA3 expression maintained in regional metastases?: a study of paired primary and metastatic urothelial carcinomas.

Zhao L, Antic T, Witten D, Paner GP, Taxy JB, Husain A, Gwin K, Mirza MK, Lingen MW, Tretiakova MS.

Am J Surg Pathol. 2013 Dec;37(12):1876-81. doi: 10.1097/PAS.0b013e31829e2525.

PMID:
24121175
[PubMed - indexed for MEDLINE]
6.

Immunohistochemistry in the differential diagnosis between primary and secondary intestinal adenocarcinoma of the urinary bladder.

Raspollini MR, Nesi G, Baroni G, Girardi LR, Taddei GL.

Appl Immunohistochem Mol Morphol. 2005 Dec;13(4):358-62.

PMID:
16280666
[PubMed - indexed for MEDLINE]
7.

Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung.

Chang A, Amin A, Gabrielson E, Illei P, Roden RB, Sharma R, Epstein JI.

Am J Surg Pathol. 2012 Oct;36(10):1472-6. doi: 10.1097/PAS.0b013e318260cde7.

PMID:
22982890
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Clinical utility of immunohistochemistry in the diagnoses of urinary bladder neoplasia.

Hodges KB, Lopez-Beltran A, Emerson RE, Montironi R, Cheng L.

Appl Immunohistochem Mol Morphol. 2010 Oct;18(5):401-10. doi: 10.1097/PAI.0b013e3181e04816. Review.

PMID:
20505509
[PubMed - indexed for MEDLINE]
9.

Primary bladder adenocarcinoma versus metastatic colorectal adenocarcinoma: a persisting diagnostic challenge.

Roy S, Smith MA, Cieply KM, Acquafondata MB, Parwani AV.

Diagn Pathol. 2012 Nov 2;7:151. doi: 10.1186/1746-1596-7-151.

PMID:
23121893
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.

Higgins JP, Kaygusuz G, Wang L, Montgomery K, Mason V, Zhu SX, Marinelli RJ, Presti JC Jr, van de Rijn M, Brooks JD.

Am J Surg Pathol. 2007 May;31(5):673-80.

PMID:
17460449
[PubMed - indexed for MEDLINE]
11.

Differentiation of ovarian mucinous carcinoma and metastatic colorectal adenocarcinoma by immunostaining with beta-catenin.

Chou YY, Jeng YM, Kao HL, Chen T, Mao TL, Lin MC.

Histopathology. 2003 Aug;43(2):151-6.

PMID:
12877730
[PubMed - indexed for MEDLINE]
12.
13.

GATA-3 immunohistochemistry in the differential diagnosis of adenocarcinoma of the urinary bladder.

Ellis CL, Chang AG, Cimino-Mathews A, Argani P, Youssef RF, Kapur P, Montgomery EA, Epstein JI.

Am J Surg Pathol. 2013 Nov;37(11):1756-60. doi: 10.1097/PAS.0b013e31829cdba7.

PMID:
24061521
[PubMed - indexed for MEDLINE]
14.

Expression of the urothelial differentiation markers GATA3 and placental S100 (S100P) in female genital tract transitional cell proliferations.

Esheba GE, Longacre TA, Atkins KA, Higgins JP.

Am J Surg Pathol. 2009 Mar;33(3):347-53. doi: 10.1097/PAS.0b013e3181908e24.

PMID:
19092634
[PubMed - indexed for MEDLINE]
15.

Immunohistochemical expression of prostatic antigens in adenocarcinoma and villous adenoma of the urinary bladder.

Lane Z, Hansel DE, Epstein JI.

Am J Surg Pathol. 2008 Sep;32(9):1322-6. doi: 10.1097/PAS.0b013e3181656ca0.

PMID:
18670358
[PubMed - indexed for MEDLINE]
16.

Use of novel immunohistochemical markers expressed in colonic adenocarcinoma to distinguish primary ovarian tumors from metastatic colorectal carcinoma.

Logani S, Oliva E, Arnell PM, Amin MB, Young RH.

Mod Pathol. 2005 Jan;18(1):19-25.

PMID:
15389251
[PubMed - indexed for MEDLINE]
Free Article
17.

Use of PAX8 and GATA3 in diagnosing sarcomatoid renal cell carcinoma and sarcomatoid urothelial carcinoma.

Chang A, Brimo F, Montgomery EA, Epstein JI.

Hum Pathol. 2013 Aug;44(8):1563-8. doi: 10.1016/j.humpath.2012.12.012. Epub 2013 Feb 28.

PMID:
23453625
[PubMed - indexed for MEDLINE]
18.

Primary mucin-producing urothelial-type adenocarcinoma of prostate: report of 15 cases.

Osunkoya AO, Epstein JI.

Am J Surg Pathol. 2007 Sep;31(9):1323-9.

PMID:
17721186
[PubMed - indexed for MEDLINE]
19.

Hepatocyte nuclear factor-1β expression in clear cell adenocarcinomas of the bladder and urethra: diagnostic utility and implications for histogenesis.

Brimo F, Herawi M, Sharma R, Netto GJ, Epstein JI, Illei PB.

Hum Pathol. 2011 Nov;42(11):1613-9. doi: 10.1016/j.humpath.2011.01.007. Epub 2011 Apr 14.

PMID:
21496868
[PubMed - indexed for MEDLINE]
20.

Immunohistochemical study of E-cadherin and β-catenin expression in colorectal carcinomas.

Ozgüven BY, Karaçetin D, Kabukçuoğlu F, Taşkin T, Yener Ş.

Pol J Pathol. 2011;62(1):19-24.

PMID:
21574102
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk